Ferrer, Poirot & Wansbrough | Injury Law Blog

Research Shows Surgery Boosts Mesothelioma Survival Rate

by Keith Adkins | May 19th, 2015

Mesothelioma is a deadly form of cancer of the lungs and body cavity. The disease often develops in patients who have been exposed to high levels of asbestos, a naturally occurring substance found in many of the work environments and products that are available to consumers in the United States.

There are numerous treatments to help patients battle mesothelioma, but the defective product lawyers at Ferrer, Poirot & Wansbrough explain that some of the methods are more effective than others.

A study that was released in the April issue of Oncology states that, of the 14,288 cases of mesothelioma that researchers examined, patients who underwent surgery to remove a tumor or reduce the size of the growth had the most promising survival rates.

Researchers looked at the age, sex, race, date of diagnosis, and other factors of a patient in order to divide the massive pool of participants into groups for data collection. The data determined that surgery seems to have the greatest impact on survival, while surgery combined with radiation shared similar results.

Despite improvements in medical technology and patient care, mortality rates for mesothelioma patients has not wavered from the average 18 months of life following a diagnosis.

If you’ve been diagnosed with mesothelioma, you likely have many questions regarding your rights. Speaking with a mesothelioma lawyer at Ferrer, Poirot & Wansbrough can help.

 

Bookmark and Share

$2.4 Billion Settlement Offered to Actos® Drug Injury Lawsuit Plaintiffs

by Keith Adkins | May 12th, 2015

Actos® is a drug that can treat diabetes, but studies show that the drug may significantly increase the chances of patients developing bladder cancer. Unfortunately, the risk wasn’t communicated to many patients who took the drug.

As a result, patients who developed bladder cancer after taking Actos filed drug injury lawsuits against the manufacturer of Actos, Takeda Pharmaceutical. Several of those cases went to trial with mixed results. And now Takeda has announced that it wishes to settle a majority of the remaining Actos drug injury lawsuits for an estimated $2.4 billion.

According to The New York Times, the settlement will only be finalized if 95 percent of the plaintiffs who qualify agree to the terms of the offer. The cutoff for victims to submit their approval or denial is mid-July. If the settlement is finalized, victims can expect to see payments up to $296,000 each.

At Ferrer, Poirot & Wansbrough, our drug injury lawyers are hopeful that Actos injury victims and their families get the compensation they deserve.

 

Bookmark and Share

FDA Issues Warnings Regarding Testosterone Therapy Heart Attack Risks

by Keith Adkins | May 5th, 2015

Testosterone is a hormone that helps regulate energy levels, body mass, and sex drive in males. Several medications can raise a man’s testosterone levels, but it’s important to note the U.S. Food and Drug Administration (FDA) has only approved a majority of these drugs to treat certain medical conditions—not low testosterone levels resulting from aging.

Despite the FDA’s regulations, these treatments continue to be prescribed to patients considered unfit to take the drugs. Studies have shown men with a history of heart disease who use low testosterone therapy drugs have an increased Testosterone therapy heart attack risk.

These risks have prompted the FDA to issue a press release warning drug manufacturers and medical professionals about the drug injury risks. Furthermore, the agency issued a press release calling for updates to the labels of low testosterone therapy drugs that would clearly state a warnings to patients.

The FDA goes on to recommend that anyone using a low testosterone therapy drug who experiences symptoms of a heart attack should speak with a medical professional immediately.

At Ferrer, Poirot & Wansbrough, our drug injury lawyers are hopeful these new warnings will be successful in reducing the amount of Low T treatment heart attacks.

Bookmark and Share

FDA Launches Mucinex® Recall Due to Acetaminophen Overdose Risks

by Keith Adkins | April 28th, 2015

Acetaminophen can be used to effectively control and treat pain. However, taking too much of this drug can lead to serious harm. Some symptoms of an acetaminophen overdose can be:

  • Abdominal pain
  • Vomiting
  • Convulsions
  • Liver damage

To help reduce acetaminophen injuries, products containing the medication are labeled to display information such as safety warnings and proper dosages. Drugs with improper labeling are subject to recalls.

According to KSN News, the U.S. Food and Drug Administration (FDA) has initiated such a recall on Mucinex® products due to mislabeling, including certain lots of:

  • MUCINEX® FAST-MAX® Night Time Cold & Flu
  • MUCINEX® FAST-MAX® Cold & Sinus
  • MUCINEX® FAST-MAX® Severe Congestion & Cough
  • MUCINEX® FAST-MAX® Cold, Flu & Sore Throat

The drugs were recalled because information on the front labels of the products did not match the information found on the back labels of the product. Anyone in possession of the affected product has been instructed to mix the product with inedible items in a plastic bag before properly disposing of it.

If you’ve been harmed by a recalled drug, the drug injury lawyers at Ferrer, Poirot & Wansbrough want to protect your rights. Call us 24/7 to get in touch with our legal staff—just dial (866) 589-0257.

Bookmark and Share

Drug Injury Lawyers Discuss Improper Medication and Medical Device Labeling

by Keith Adkins | April 21st, 2015

What happens when important safety information is omitted from a drug or medical device label? The drug injury lawyers at Ferrer, Poirot & Wansbrough explain that, unfortunately, medical product labels may not always carry all the necessary information required by law—which can often lead to injury.

An article from Healthcare Packaging touched on two specific cases where drug manufacturers failed to supply adequate information on a label. And, in one case, even allegedly used packaging sizes to manipulate consumers into buying certain products.

Pfizer, Inc. supposedly placed misleading labels on certain products. This caused consumers receive less information than they were supposed to while boosting sales of items that contained less product than it seemed to hold.

Another article stated Ban, a deodorant manufacturer, is also being sued after research uncovered the company wasn’t supplying consumers with as much product as was printed on the label.

If you’ve been harmed by a defective medical device, you may have rights to compensation. The attorneys at Ferrer, Poirot & Wansbrough want to help. Call us anytime at (866) 589-0257 to discuss your case.

Bookmark and Share

New Sanitation Policies Help Prevent Medical Devices From Spreading Contamination

by Keith Adkins | April 14th, 2015

After a deadly “superbug” contamination left hundreds of patients ill and fighting for their lives in numerous hospitals across the country, the U.S. Food and Drug Administration (FDA) has announced they’re taking action to prevent such incidents in the future.

The defective medical device lawyers with Ferrer, Poirot & Wansbrough explain that hospitals are required to vigorously clean all devices and equipment used to perform procedures. Sometimes though, the sanitation steps that are taken just aren’t enough.

Officials have determined this lack of effective sanitation procedures is what allowed a drug-resistant strain of bacteria called carbapenem-resistant Enterobacteriaceae, or CRE, to be spread through specialized endoscopes.

The devices were used to gather images from inside the bodies of patients to determine what was ailing them. However, when the devices were not being effectively cleaned, patients were exposed to the CRE superbug.

This lack of effective sanitation prompted the FDA to issue a press release with a new set of standards to be utilized when sterilizing medical devices that are reprocessed.

The new standards require more extensive safety testing before the device can be released to the public. Manufacturers of medical devices are also encouraged to take reprocessing into consideration when designing new products.

At Ferrer, Poirot & Wansbrough, our personal injury attorneys are hopeful the new procedures being implemented will reduce the rates of hospital-acquired infections in patients after medical procedures.

 

Bookmark and Share

FDA Recalls Defective Medical Device Due to Knee Implant Complications

by Keith Adkins | April 7th, 2015

As the importance of staying active and healthy later in life becomes more and more apparent, there has been a dramatic increase in the number of patients who must undergo corrective or replacement surgery on their knees. It’s important for people considering such a procedure to be aware of the dangers of knee implant complications.

Some of the most common problems reported by knee replacement patients are pain, swelling, and infection, but more serious complications have been reported in the past. In fact, some devices have been found to wear prematurely.

Such issues prompted the U.S. Food and Drug Administration to announce the Class II recall of the Zimmer Persona Trabecular Metal Tibial Plate. Reports indicate that a large number of patients who received the device have complained about radiolucent lines and loosening of the unit. These issues could result in a dislocation of the unit, as well as other severe complications.

All lots and sizes of the device should be returned to the manufacturer immediately.

If you’ve been harmed by a defective medical device, you may have legal rights to compensation. Ferrer, Poirot & Wansbrough is here to assist you. You can reach us 24/7 by calling (866) 589-0257.

Bookmark and Share

Fentanyl Pain Patch Lawyers Talk About Risks of Opioid Medications

by Keith Adkins | March 31st, 2015

Imagine suffering so much pain on a daily basis that taking a breath is a chore. For many Americans, this nightmare is a reality. Luckily, medications available to treat severe and chronic pain, but certain versions of these drugs can present serious health risks.

Fentanyl is an opioid medication that only needs to come in contact with a patient’s skin for the effects to be felt. Fentanyl is administered through a sticky patch placed on the skin. The drug is then absorbed through the skin and is slowly released into the bloodstream.

The problem with the Fentanyl pain patch is its strength.

Data from the Centers for Disease Control and Prevention explains that 120 people die each day in the U.S. as the result of drug overdoses. Opioid medications, like Fentanyl, are responsible for a majority of overdoses.

The issue with the Fentanyl pain patch is that the dosage of drug the patient receives is determined strictly by the size of the patch that’s administered. The Fentanyl pain patch lawyers at Ferrer, Poirot & Wansbrough explain that if a patient is given too much of the drug through a larger than needed patch, the patient is at risk of cardiac and respiratory failure, or even death.

If you or a loved one have suffered such an injury after using a Fentanyl pain patch, our drug injury lawyers would suggest speaking with a legal professional about your rights.

Bookmark and Share

Drug Injury Attorneys Take a Look at Zofran® Birth Defects

by Keith Adkins | March 24th, 2015

Drug manufacturer GlaxoSmithKline released Zofran®, a powerful anti-nausea drug, several years ago as for use in patients undergoing chemotherapy. The drug soon began to be marketed off label to treat pregnant women suffering from morning sickness. Since that time, it has come to light that taking Zofran can cause unborn children of pregnant mothers to be born with birth defects.

One of the most common Zofran birth defects are heart defects, which can have lifelong health effects and require corrective surgery.

An article from KVLY 11 News tells the story of a two-year-old girl born with heart problems after her mother took Zofran during pregnancy. The condition wasn’t discovered until recently when the child underwent an X-ray. Now, the child must undergo open-heart surgery to close two holes in her heart.

A benefit is being held to help raise funds for the child’s medical costs, but the drug injury attorneys with Ferrer, Poirot, & Wansbrough explain that familes of Zofran birth defect victims may also be eligible for compensation.

Filing a drug injury lawsuit can be complicated, which is why we suggest speaking with an attorney about your case as soon as possible. Doing so can help ensure your legal rights to compensation are protected throughout the legal process.

Bookmark and Share

FDA Issues Warnings About Low T Therapy Heart Attack Risks

by Keith Adkins | March 17th, 2015

Testosterone is a male hormone that assists in the regulation of body mass, mood, energy level, and sex drive. As men age, their bodies produce less of this hormone, which can result in changes affecting a variety of body systems.

Some medical professionals have developed treatments for decreased testosterone levels known as low testosterone (Low T) therapy. For many, this seems like a wonderful solution to their problems, but the U.S. Food and Drug Administration (FDA) recently issued a warning regarding Low T therapy health risks.

Officials say that the use of testosterone products or undergoing Low T therapy could put patients at risk of suffering a heart attack or stroke. The FDA is also requiring changes in the labeling of drugs being used in testosterone therapy to carry warnings about Low T therapy heart attack risks.

The warnings go on to instruct patients to consult their physicians immediately if they experience any signs of a heart attack, including shortness of breath or chest pain. Anyone who suffers adverse health events associated with Low T therapy should also report the incident to the FDA immediately.

At Ferrer, Poirot & Wansbrough, our team of drug injury lawyers has advocated for numerous patients harmed by drugs and medical devices, and we are here to help if you’ve suffered a testosterone therapy injury. We’re available to answer your questions—just dial (866) 589-0257.

Bookmark and Share